Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
800 participants
OBSERVATIONAL
2016-10-01
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognostic Study of HPV Virus Integration in Women With HSIL
NCT05745597
A Multicenter Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL
NCT05282745
Clinical Evaluation of Detection of High Risk HPV in Urine
NCT05210348
HPV Integration Testing for Cervical Cancer Screening
NCT02576158
All-cause and Diseases-specific Mortality of High-risk HPV Infection
NCT06631495
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Research design:First, to do the retrospective analysis toward the patients who received conization between Jan 2009 to Aug 2016.Second,to do the prospective analysis toward the patients who received conization between Spt 2016 to Aug 2018.
Inclusive criteria of study population:The patients who had finished HPV genotype testing before conization;who had never received treatment other than conization;who were histologically diagnosed as HSIL or IA1 cervical squamous cancer;who had not been diagnosed as any cervical diseases before;who were under age 70;who did not have any severe diseases that influence the follow-up.
Follow-up methods:to do the follow-up to the target patients by 3,6,9,12,18,24 months after conization.
Follow-up contents:the HR-HPV genotype infection before conization;the grade of lesion;the age when received conization;the gravity and parity;the situation of the glands invovement
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HSIL
the patients with HSIL
HPV genotype test
HPV genotype test is a diagnostic test by smearing the cervix to find out whether a patient is hpv infected, and if infected, the test can descover the concrete hpv genotype.
stage IA1 cervical squamous cancer
the patients with stage IA1 cervical squamous cancer
HPV genotype test
HPV genotype test is a diagnostic test by smearing the cervix to find out whether a patient is hpv infected, and if infected, the test can descover the concrete hpv genotype.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HPV genotype test
HPV genotype test is a diagnostic test by smearing the cervix to find out whether a patient is hpv infected, and if infected, the test can descover the concrete hpv genotype.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* histologically diagnosed as HSIL or stage IA1 cervical squamous cancer
* received conization in Beijing Obstetrics and Gynecology Hospital
* HR-HPV infected without any treatment other than conization
* HR-HPV genotype tested before coniztion
Exclusion Criteria
* with severe desease that influence the follow-up
* received other treatment on cervical lesion
* data incompleted
* not meet the inclusive criteria
18 Years
70 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Capital Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yu mei Wu
Yu mei Wu
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yu mei Wu, Doctor
Role: STUDY_DIRECTOR
Beijing Obstetrics and Gynecology Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yu mei Wu
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yu mei Wu, Doctor
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZYLX201705
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.